Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Effect of CagriSema on achievement of composite HbA1c and body weight reduction targets in participants with type 2 diabetes: REIMAGINE 1 ​

Authors :

A. B. Jain1,2; J. Aberle3; R. Adhya4; L. K. Billings5; R. Gajria6; T. Watt6; R. Pop-Busui7

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Keywords
Diabetes
Congress oral presentation
Amylin
CagriSema
PHASE 3 (RCT)